The difference in aortic plaque size between the Tet2-deficient mice and control mice was abrogated by use of an NLRP3 inhibitor, identifying a key role for NLRP3-mediated IL-1β overproduction in promoting atherosclerosis in those harboring TET2 CHIP mutations. This evidence concerns the gene NLRP3 and atherosclerosis.